Cordarone

Known as: Amiodarex, Sanofi Winthrop Brand of Amiodarone Hydrochloride, Cordarex 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Hypotension is the most frequent adverse event reported with intravenous amiodarone (Cordarone IV). The hypotension has been… (More)
Is this relevant?
2004
2004
Hypotension is the most frequent adverse event reported with intravenous amiodarone. Hypotension has been attributed to the… (More)
Is this relevant?
2004
2004
Objective: This study was designed to test the hypothesis that rapid bolus administration of an aqueous formulation of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
INTRODUCTION The Resuscitation 2000 Guidelines recommends amiodarone as the antiarrhythmic drug of choice in treatment of… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
1998
1998
Amiodarone is an antiarrhythmic drug widely used to treat a variety of supraventricular and ventricular arrhythmias. However its… (More)
Is this relevant?
1994
1994
Chronic atrial fibrillation is a common dysrhythmia that carries a substantial risk for stroke. The prevalence of atrial… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1993
1993
The present study was intended to examine the stability of amiodarone (Cordarex, CAS 1951-25-3) and its metabolite… (More)
Is this relevant?
1988
1988
Amiodarone-induced bilateral diffuse pulmonary fibrosis developed in a 47-year-old woman with idiopathic hypertrophic subvalvular… (More)
Is this relevant?
1988
1988
In 20 patients undergoing coronary arteriography, the hemodynamic effects of an experimental preparation of i.v. amiodarone 5 mg… (More)
Is this relevant?
1986
1986
Amiodarone has repeatedly been shown to have potent class III antiarrhythmic properties. It has, however, been questioned whether… (More)
Is this relevant?